[Unexpected discovery of a fetus with DMD gene deletion using single nucleotide polymorphism array]
Shaobin Lin1, Yu Zhou, Bingyi Zhou
1Fetal Medicine Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China. guheng8826@163.com.
Single nucleotide polymorphism array (SNP array) identified a de novo deletion in the DMD gene of a fetus, potentially causing Duchenne/Becker muscular dystrophy (DMD/BMD). This highlights SNP array
Area of Science:
- Genetics
- Fetal Medicine
- Genomic Medicine
Background:
- Duchenne/Becker muscular dystrophy (DMD/BMD) is a severe genetic disorder.
- Identifying de novo mutations in fetuses is crucial for genetic counseling.
- Standard karyotyping may miss small deletions in genes like DMD.
Purpose of the Study:
- To evaluate the utility of SNP array for detecting de novo DMD gene mutations in fetuses.
- To assess SNP array's effectiveness in cases with unexplained fetal conditions and no family history.
Main Methods:
- Performed G-banded karyotyping and SNP array on fetal amniocytes.
- Utilized multiplex ligation-dependent probe amplification (MLPA) to confirm DMD gene deletions/duplications.
- Analyzed maternal peripheral blood using MLPA.
Main Results:
- Karyotyping revealed a normal 46,XY karyotype.
- SNP array detected a 116 kb deletion encompassing DMD gene exons 17-29 (chrX: 32 455 741-32 571 504).
- MLPA confirmed the fetal deletion but found no mutations in the mother.
Conclusions:
- The identified de novo deletion in the DMD gene may lead to DMD/BMD.
- SNP array enhances the detection of fetal genomic disorders, especially with unknown genes, negative family history, or nonspecific symptoms.
More Related Videos
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
